Evidence map›Paper›PMID 42104242›Full record

ArticleBMC medical research methodology2026

Survival analysis of left-truncated and right-censored HIV data: comparison of Cox regression and alternative models.

Tuba Çakır, Yüksel Terzi

Abstract readComparative Study
In one paragraph

Article in BMC medical research methodology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Tuba ÇakırDepartment of Finance and Banking, Görele School of Applied Sciences, Giresun University, Görele, Giresun, 28800, Türkiye. tuba.sanli@giresun.edu.tr.ORCID http://orcid.org/0000-0001-6019-8037
Yüksel TerziDepartment of Statistics, Faculty of Science, Ondokuz Mayıs University, Atakum, Samsun, Türkiye.ORCID http://orcid.org/0000-0003-4966-8450

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThis study examined the impact of delayed entry in HIV cohorts by analyzing left-truncated and right-censored (LTRC) survival data from 69 HIV-positive male patients (24 deaths) followed at a tertiary infectious diseases center. The primary objective was to empirically compare commonly used survival models in estimating survival and identifying prognostic factors under LTRC conditions.

methodsThree LTRC-adapted modeling frameworks were applied with identical covariates: the semiparametric Cox proportional hazards model, accelerated failure time (AFT) models, and parametric proportional hazards models. Median survival time was estimated using Kaplan-Meier methods under both right-censoring-only and LTRC specifications to assess truncation-related differences. Hazard ratios (HRs) and 95% confidence intervals (CIs) were obtained from the LTRC-adjusted Cox model. Model performance was evaluated using information criteria (AIC, BIC, HQIC).

resultsIgnoring left truncation substantially inflated median survival estimates (3,885 vs. 2,626 days). In the LTRC-adjusted Cox model, age (HR = 1.049, 95% CI: 1.011-1.089) and log-transformed HIV RNA (HR = 1.214, 95% CI: 1.055-1.400) were significant predictors, whereas CD4 count and comorbidity status were not. Among the evaluated models, the Cox model showed the lowest information criterion values within this dataset.

conclusionsAppropriate risk-set specification under left truncation is essential for reliable survival estimation in delayed-entry HIV cohorts. Within this empirical dataset, the LTRC-adapted Cox model showed favorable performance relative to AFT and parametric PH alternatives.

Indexed as

HIV InfectionsAdultHumansKaplan-Meier EstimateMaleMiddle AgedPrognosisProportional Hazards ModelsSurvival AnalysisAccelerated failure time modelsCox proportional hazards modelHIV survivalLeft truncationRight censoringSurvival analysis

Identifiers

PMID42104242
PMCPMC13326239

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.